Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 30 of 43, showing 5 Applications out of 212 total, starting on record 146, ending on 150

# Protocol No Study Title Investigator(s) & Site(s)

146.

ECCT/23/07/03   ARNASA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Professor Videlis Nduba
2. Professor Videlis Nduba
Site(s) in Kenya
1. KENYA MEDICAL RESEARCH INSTITUTE-CENTRE FOR RESPIRATORY DISEASE RESEARCH (CRDR) (Nairobi City county)
2. KEMRI/CRDR, Siaya Clinical Research Annex (Siaya county)
3. Clinical Research Health Network (CREA-N) (Machakos county)
4. KEMRI-Mtwapa Clinical Annex (Kilifi county)
5. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
6. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
7. University of Nairobi Clinical Research Centre (Nairobi City county)
 
View

147.

ECCT/23/07/04   PRAISE
    An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE)   
Principal Investigator(s)
1. Dr. Janet Oyieko
Site(s) in Kenya
1. Kondele Children\'s Hospital Center for Clinical Research (CCR), (Kisumu county)
2. Gertrude\'s Children Hospital (Nairobi City county)
3. KEMRI/CRDR Kemri Clinical Research Annex (Siaya county)
 
View

148.

ECCT/23/08/01   ARNASA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Dr Teresa Kinyari
Site(s) in Kenya
1. University of Nairobi Clinical Research Centre (Nairobi City county)
2. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
3. Clinical Research Health Network (CREA-N) (Machakos county)
4. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county)
5. KEMRI-Mtwapa Clinical Annex (Kilifi county)
6. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
 
View

149.

ECCT/23/08/02   PRAISE
    An Adaptive, Randomized, Placebo-controlled, Double-blind, Multi-center Study of Oral FT-4202, a Pyruvate Kinase Activator in Patients with Sickle Cell Disease (PRAISE)   
Principal Investigator(s)
1. Nduba Videlis
Site(s) in Kenya
1. Getrudes Children Hospital (Nairobi City county)
2. KEMRI/CRDR (Siaya county)
3. Kombewa CRC (Kisumu county)
4. Kondele Childrens Hospital (Kisumu county)
 
View

150.

ECCT/23/09/01   ARNASA
    A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ASTEGOLIMAB IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE   
Principal Investigator(s)
1. Dr Mary Matilu
Site(s) in Kenya
1. KEMRI-Mtwapa Clinical Research Annex, (Kilifi county)
2. University of Nairobi Clinical Research Centre (Nairobi City county)
3. Center for Research In Tropical Medicine and Community Development (Nairobi City county)
4. Clinical Research Health Network (CREA-N) (Machakos county)
5. KEMRI-CRDR Siaya Clinical Research Annex (Siaya county)
6. KEMRI-CRDR Clinical Research Annex (Nairobi City county)
7. Clinical Research Health Network (CREA-N) (Machakos county)
 
View